COL1A1 and colitis: TNBS administration significantly reduced body weight and upregulated mRNA levels coding for fibrosis markers such as Acta2, Col1a1 and Vim. Spironolactone treatment had no significative effect on the studied parameters compared to rats with chronic TNBS colitis.